Fundraising FoxMission Therapeutics
6 known investors
Find your way into Mission Therapeutics
Sign up to see every warm intro you have to Mission Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Mission Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Mission Therapeutics develops therapeutics targeting deubiquitylating enzymes (DUBs), such as USP30, which regulate ubiquitylation and processes including mitophagy and protein homeostasis. It operates in the biotech and drug discovery field focused on DUB biology.
Investors · 6
How we know: funding news · the VCSheet dataset · Not right? Tell us
How we know: Roche Venture Fund's portfolio page · funding news · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Rosetta Capital Ltd.'s portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Sofinnova Partners's portfolio page · a partner's Signal profile · funding news · open dataset · 5k.vc investor directory · Not right? Tell us
Related companies · 2
Companies working in the same space as Mission Therapeutics.
In the news
Frequently asked questions
- What does Mission Therapeutics do?
- Mission Therapeutics develops therapeutics targeting deubiquitylating enzymes (DUBs), such as USP30, which regulate ubiquitylation and processes including mitophagy and protein homeostasis. It operates in the biotech and drug discovery field focused on DUB biology.
- Who are Mission Therapeutics's investors?
- Mission Therapeutics's investors include Pfizer Venture Investments, Roche Venture Fund, Rosetta Capital Ltd., Sofinnova Partners, SR One Capital Management, IP Group.